Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cannabist Co Holdings (CBSTF) EBITDA (2021 - 2025)

Cannabist Co Holdings' EBITDA history spans 5 years, with the latest figure at -$14.7 million for Q3 2025.

  • For Q3 2025, EBITDA fell 731.25% year-over-year to -$14.7 million; the TTM value through Sep 2025 reached -$179.4 million, down 40.52%, while the annual FY2024 figure was -$105.1 million, 39.68% up from the prior year.
  • EBITDA for Q3 2025 was -$14.7 million at Cannabist Co Holdings, up from -$77.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $49000.0 in Q2 2023 and bottomed at -$360.8 million in Q4 2022.
  • The 5-year median for EBITDA is -$18.7 million (2022), against an average of -$46.2 million.
  • The largest annual shift saw EBITDA soared 100.22% in 2023 before it crashed 27942.86% in 2024.
  • A 5-year view of EBITDA shows it stood at -$84.8 million in 2021, then crashed by 325.2% to -$360.8 million in 2022, then skyrocketed by 78.46% to -$77.7 million in 2023, then rose by 29.01% to -$55.2 million in 2024, then surged by 73.43% to -$14.7 million in 2025.
  • Per Business Quant, the three most recent readings for CBSTF's EBITDA are -$14.7 million (Q3 2025), -$77.4 million (Q2 2025), and -$32.2 million (Q1 2025).